Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.
Thomas Münzel, from Johannes Gutenberg University in Germany, and colleagues developed an expert consensus paper to address nicotine itself as a direct cardiovascular toxin, independent of combustion ...
HealthDay News — The US Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary ...
The AAP represents about 67,000 pediatricians nationwide. The cuts come amid ongoing disagreements over vaccines.
The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...
Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
The new legislations hope to amend the Higher Education Act of 1965 to restore the full loan limits that were narrowed under Trump’s so-called “Big Beautiful Bill." ...
Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.
A group of 6 nurse practitioners, all working for the State of New York, filed a class action complaint against the state and the New York State Civil Service Commission, alleging gender bias and wage ...
Findings seen for older adults experiencing gabapentinoid (gabapentin and pregabalin)-edema-loop diuretic prescribing cascade ...
“Consistent with prior work, we observed low adherence (7.3%) to cervical cancer screening guidelines among the commercially insured US population despite stable coverage, likely reflecting guideline ...
Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results